EDIT NEWS why is Editas Medicine, Inc. price falling or rising

EDIT NEWS reasons for why stock price of Editas Medicine, Inc. is falling or rising

EDIT Editas Medicine is falling or rising technical reasons

Technical analysis forecast for Editas Medicine Stock is that its in a downtrend for shortterm, and I will avoid taking a BUY or a LONG trade in this stock. Look for opportunities to sell or SHORT Editas Medicine EDIT at this time. Stock is falling and might fall more.

It appears as if Editas Medicine EDIT gave a large move recently.

Stock of Editas Medicine (EDIT) is trading below an important moving average line, and it has been below this line for quite some time now. This is not a good sign, stock might keep falling and stock might move lower...

My analysis of Editas Medicine is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if Editas Medicine stays below 2.1, but if it comes above 2.1, then a intra day buy could be more profitable.
If you take a sell trade below 2.1, then use 2.1 as stoploss and 1.6 as target. However if you take a buy trade in Editas Medicine, then use 2.1 as stoploss and 2.53 as target.

EDIT Editas Medicine is falling or rising NEWS fundamental reasons

Deposit growth in line with credit growth at 10.6% Public deposits with scheduled commercial banks saw a 10.6% surge, reaching Rs 224.7 lakh crore by November 29, 2024. Both term and demand deposits achieved double-digit growth, mirroring the 10.6% rise in bank credit to Rs 179.6 lakh crore. This growth r - NEWS as on 2024-12-12 indiatimes.com

Assocham seeks input tax credit on fitout services at managed workspaces Assocham has urged the government to grant input tax credit (ITC) to managed workspace companies for fitout services provided to tenants. This move aims to reduce costs, boost demand, and increase GST revenue. The current GST law restricts ITC claims, hi - NEWS as on 2024-12-05 indiatimes.com

Bank credit growth slows to 11.1% despite a mega merger Indian bank lending slowed to 11.1% this year. Last year it was 20.6%. Deposit growth also fell to 11.2% from 13.6%. Banks added fewer loans and deposits compared to the previous year. Slower credit growth may impact India's GDP. Banks are selling gov - NEWS as on 2024-12-04 indiatimes.com

Pace of credit card additions falls 50% in October Credit card additions at Indian banks dropped nearly 50% in October year-on-year amid rising delinquencies and stricter RBI risk weight regulations. Lenders remain cautious with new disbursements as there are signs of demand fatigue in the consumption mark - NEWS as on 2024-12-04 indiatimes.com

Banks should adopt 'bottom-up' approach for preparing credit plan: RBI's Swaminathan RBI Deputy Governor Swaminathan J suggested that banks use a bottom-up approach to prepare credit plans to meet the fund needs of different segments in districts. He emphasized using field surveys for data collection and focusing on underserved groups like - NEWS as on 2024-12-03 indiatimes.com

Bajaj Fin may exit credit card partnership with DBS, Motilal Oswal says Bajaj Finance may also end its co-branded card partnership with DBS Bank, resulting in a potential decline in fee income by Rs 47 crore in the current fiscal and Rs 140 crore by March 2026. Despite lost upfront fee income, income from the trail fee stream - NEWS as on 2024-12-02 indiatimes.com

Ending Bajaj Fin credit card tie-up a non-event, pace of new sales to return in a quarter: RBL Bank RBL Bank is set to regain its credit card sales pace within a quarter following the end of its tie-up with Bajaj Finance. About 30% of its cards remain co-branded, but new distribution strategies and partnerships, including IRCTC and Mahindra Finance, aim - NEWS as on 2024-12-01 indiatimes.com

Tight credit and external uncertainty to weigh on India’s growth: Sonal Varma ​Government spending should pick up compared to first half, particularly on the capital expenditure side, and better crop prospects that also does bode well for agriculture production and rural demand, but in the overall scheme of things we do think that - NEWS as on 2024-11-29 indiatimes.com

More announcements and NEWS

EDIT Editas Medicine, Inc. current price & indicator signals

Moving Averages for Editas Medicine, Inc.

  • 5Day Average: 2.15
  • 12Day Average: 2.33
  • 20Day Average: 2.64
  • 50Day Average: 3
  • 100Day Average: 3.63
  • 150Day Average: 4.18
  • 200Day Average: 4.96

EDIT Indicators & signals

Indicator MACD (12,26,9)

2.35, 2.63, -0.23
Indicator MACD is in negative zone

Indicator ADX (14)

6.67, 35, 40
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EDIT Editas Medicine, Inc. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
11 Wed Dec 2024 1.99 1.90 to 2.14 -5.24% 0.99 times
10 Tue Dec 2024 2.10 2.10 to 2.23 -5.83% 0.5 times
09 Mon Dec 2024 2.23 2.16 to 2.37 0.9% 0.87 times
26 Tue Nov 2024 2.21 2.14 to 2.34 0% 1.15 times
26 Tue Nov 2024 2.21 2.14 to 2.34 -7.14% 1.15 times
25 Mon Nov 2024 2.38 2.35 to 2.53 -2.46% 2 times
22 Fri Nov 2024 2.44 2.33 to 2.54 2.95% 0.81 times
21 Thu Nov 2024 2.37 2.30 to 2.47 -1.66% 1.03 times
20 Wed Nov 2024 2.41 2.35 to 2.48 -2.82% 1 times
19 Tue Nov 2024 2.48 2.47 to 2.56 -1.59% 0.74 times
18 Mon Nov 2024 2.52 2.51 to 2.69 -5.26% 0.75 times
15 Fri Nov 2024 2.66 2.59 to 2.80 -3.97% 0.89 times

Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 Videos related to: EDIT NEWS why is Editas Medicine, Inc. price falling or rising

Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You

Hindi Basics How To Trade In FnO Futures Options Stock Market

EDIT NEWS why is Editas Medicine, Inc. price falling or rising

 

Back to top